The effect of various neurohumoral modulators on the activity of morphine and the narcotic antagonists in the tail-flick and phenylquinone tests.
about
A proinflammatory chemokine, CCL3, sensitizes the heat- and capsaicin-gated ion channel TRPV1Clinically employed opioid analgesics produce antinociception via μ-δ opioid receptor heteromers in Rhesus monkeysSensitivity to delta9-tetrahydrocannabinol is selectively enhanced in beta-arrestin2 -/- miceImmediate rescue designs in pediatric analgesic trials: a systematic review and meta-analysis.Putative kappa opioid heteromers as targets for developing analgesics free of adverse effects.Pharmacological studies with a nonpeptidic, delta-opioid (-)-(1R,5R,9R)-5,9-dimethyl-2'-hydroxy-2-(6-hydroxyhexyl)-6,7-benzomorphan hydrochloride ((-)-NIH 11082).Inhibition of Inflammatory and Neuropathic Pain by Targeting a Mu Opioid Receptor/Chemokine Receptor5 Heteromer (MOR-CCR5).Involvement of a NO-cyclic GMP-PKG signaling pathway in nitrous oxide-induced antinociception in miceThe analgesic-like properties of the alpha7 nAChR silent agonist NS6740 is associated with non-conducting conformations of the receptor.Involvement of phospholipid signal transduction pathways in morphine tolerance in micebeta-Endorphin: development of tolerance and its reversal by 5-hydroxytryptophan in catsAgonist and antagonist properties of buprenorphine, a new antinociceptive agent.Analgesic and anti-inflammatory effects of aqueous extract of leaves of Pentatropis capensis Linn. f. (Bullock)Antinociceptive action of nicotine and its methiodide derivatives in mice and rats.Morphine efficacy is altered in conditional HIV-1 Tat transgenic mice.The antinociceptive effects of nicotinic partial agonists varenicline and sazetidine-A in murine acute and tonic pain modelsOpioid activity of spinally selective analogues of N-naphthoyl-β-naltrexamine in HEK-293 cells and mice.Analgesic activity of the naturally occurring heptapeptide [Met]enkephalin-Arg6-Phe7.The antinociceptive effects of nicotinic receptors α7-positive allosteric modulators in murine acute and tonic pain models.Nitrous oxide-antinociception is mediated by opioid receptors and nitric oxide in the periaqueductal gray region of the midbrain.Modification of the behavioral effects of morphine in rats by serotonin 5-HT₁A and 5-HT₂A receptor agonists: antinociception, drug discrimination, and locomotor activity.In vivo pharmacological interactions between a type II positive allosteric modulator of α7 nicotinic ACh receptors and nicotinic agonists in a murine tonic pain model.Ligands that interact with putative MOR-mGluR5 heteromer in mice with inflammatory pain produce potent antinociception.An overview of animal models of pain: disease models and outcome measures.Bivalent ligands that target μ opioid (MOP) and cannabinoid1 (CB1) receptors are potent analgesics devoid of tolerance.Homozygous inactivation of the LGI1 gene results in hypomyelination in the peripheral and central nervous systems.The effect of gp120 on morphine's antinociceptive and neurophysiological actions.Analgesic and anti-inflammatory studies of cyclopeptide alkaloid fraction of leaves of Ziziyphus nummularia.Analgesic and dependence studies with oripavine partial agonists.Micturition in naive and morphine-dependent rats.Modulation of morphine antinociception in the mouse by endogenous nitric oxide.The α7 nicotinic receptor dual allosteric agonist and positive allosteric modulator GAT107 reverses nociception in mouse models of inflammatory and neuropathic pain.Induced association of mu opioid (MOP) and type 2 cholecystokinin (CCK2) receptors by novel bivalent ligands.
P2860
Q24297948-6EB9BB92-A540-47CC-B4CC-FC524B82820FQ24597777-6CC3FD2C-2CCC-405F-B2A1-9858D8788540Q24647599-3B20636A-278B-4B54-BF91-900323EC5F7AQ27318455-E6161A88-5B6C-4B9B-89DC-3C429283130FQ34061067-FCA6B149-2969-4D9D-ACE7-70735E7F0FDEQ34363972-7E6093EB-0951-4607-96F4-9255E67BE33DQ34497517-AA2E7222-3BC9-4DA9-BFDA-2CBB74948913Q34633464-30DA0975-8D23-4F8C-9266-3C2016C72DE0Q35034364-35D6B4CE-D69B-403C-9084-75254CC491F2Q35041461-72FFA280-BEB5-4F86-BD84-048CBF0DAE0DQ35052976-DD3AC587-9783-403C-B985-391836693C5AQ35176503-18C0E498-22F9-4A03-BF2F-D4001CD11DF5Q35313999-24627F14-8314-4A90-8AC0-99EC643249C8Q36097889-DD51E3E7-C422-48FE-BCAB-B416873C94F9Q36109980-5C4C2448-CEDB-4C3F-8CFE-B49735636C92Q36174222-33EDD273-88B2-4C3B-A3E8-D44545A491ACQ36225640-FB86CEF9-889B-4E3A-8820-124EE4C03E96Q36407454-8D838F00-6BE2-4029-88BF-E4F01BC89C73Q36497623-CF73AF9B-DB0D-4363-AAAF-07192D2CEAF9Q36517571-CC2232D8-156E-4C7D-A050-87BB1CE9E161Q36545184-2AF63EEF-9816-49FB-AF7E-02116065665AQ36929434-712B3227-5630-49F0-A807-1F41022ACDACQ37010754-C42C8488-8414-466C-A7C7-8148E2EFC609Q37282107-B7BC89BB-D141-44BD-8A65-EB85968F0D93Q37360643-81FBEBAF-D58A-4345-8D70-DEC33523F010Q37454330-39BA0E9A-32E3-4762-87D2-08C9F71A3EB0Q37721790-46D608ED-5633-4E20-9B96-522C52932134Q39030500-BB4B0A38-158F-4876-8760-ABDDCE8EA693Q39988439-1EC735A1-BFF8-4ED1-9911-0F727E169B01Q41997145-82698981-A4C8-4DFD-87F5-4A4137190DE4Q42370950-C50349FF-9982-41F1-AD50-DC19DAD43DF6Q42406043-17B96478-31A2-4058-8406-6AB4EF3EAEC0Q43169496-7A59C3EF-F8D0-4A5F-9434-8D3F4EE03DF2
P2860
The effect of various neurohumoral modulators on the activity of morphine and the narcotic antagonists in the tail-flick and phenylquinone tests.
description
1970 nî lūn-bûn
@nan
1970年の論文
@ja
1970年学术文章
@wuu
1970年学术文章
@zh-cn
1970年学术文章
@zh-hans
1970年学术文章
@zh-my
1970年学术文章
@zh-sg
1970年學術文章
@yue
1970年學術文章
@zh
1970年學術文章
@zh-hant
name
The effect of various neurohum ...... flick and phenylquinone tests.
@en
The effect of various neurohum ...... flick and phenylquinone tests.
@nl
type
label
The effect of various neurohum ...... flick and phenylquinone tests.
@en
The effect of various neurohum ...... flick and phenylquinone tests.
@nl
prefLabel
The effect of various neurohum ...... flick and phenylquinone tests.
@en
The effect of various neurohum ...... flick and phenylquinone tests.
@nl
P2093
P1476
The effect of various neurohum ...... flick and phenylquinone tests.
@en
P2093
P304
P407
P577
1970-11-01T00:00:00Z